Myeloperoxidase (MPO) antibody and antigen (Recombinant protein)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-h-MPO-Ag01	Recombinant human MPO Protein	3090
GMP-h-MPO-Ab01	Anti-human MPO mouse monoclonal antibody (mAb)	1953
GMP-h-MPO-Ab02	Anti-human MPO mouse monoclonal antibody (mAb)	1953
GMP-h-MPO-Ab03	Anti-human MPO human monoclonal antibody (mAb)	1953
GMP-h-MPO-Ab04	Anti-human MPO human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-h-MPO-Ag01
Product Name	Recombinant human MPO Protein
Target/Biomarker	Myeloperoxidase (MPO)
Expression platform	mammalian
Isotypes	Recombinant Antigen
Bioactivity validation	Myeloperoxidase (MPO) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MPO level test of Cardiovascular disease (vascular inflammation) and related syndrome evaluation.
Tag	His
Products description	Recombinant human MPO Protein was expressed in mammalian expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-h-MPO-Ab01, GMP-h-MPO-Ab02
Product Name	Anti-human MPO mouse monoclonal antibody (mAb)
Target/Biomarker	Myeloperoxidase (MPO)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Myeloperoxidase (MPO) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MPO level test of Cardiovascular disease (vascular inflammation) and related syndrome evaluation.
Tag	mFc
Products description	Anti-human MPO mouse monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-h-MPO-Ab03, GMP-h-MPO-Ab04
Product Name	Anti-human MPO human monoclonal antibody (mAb)
Target/Biomarker	Myeloperoxidase (MPO)
Expression platform	CHO
Isotypes	Human lgG1
Bioactivity validation	Myeloperoxidase (MPO) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in MPO level test of Cardiovascular disease (vascular inflammation) and related syndrome evaluation.
Tag	hFc
Products description	Anti-human MPO human monoclonal antibody (mAb) was expressed in CHO expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Autoantibodies to MPO (MPO antineutrophil cytoplasmic antibodies: ANCA) occur in several diseases and may be involved in the pathogenesis of vascular inflammation in patients with microscopic polyangiitis (MPA). (1,2) Patients with MPA often develop MPO ANCA and may present with azotemia secondary to glomerulonephritis (pauci-immune necrotizing glomerulonephritis). MPO ANCA are not specific for MPA, and also may be detected in patients with systemic lupus erythematosus with or without lupus nephritis, Goodpasture syndrome and Churg-Strauss syndrome. Lupus nephritis and Goodpasture syndrome, as well as Wegener granulomatosis may present with azotemia and progressive renal failure. It is not possible to distinguish among these diseases on the basis of clinical signs and symptoms; autoantibody testing may be helpful.

About GDU